The Latest Breaking News from Hepatitis

The hepatitis C virus, or HCV, causes a chronic liver infection that can lead to permanent liver scarring and, in dire cases, cancer. It affects around 71 million people worldwide and causes approximately 400,000 deaths each year. While treatments are available for HCV-related infections, they are expensive, hard to access…

Chicken fillets, crisps, lasagne and ice cream are among the items that the Food Safety Authority of Ireland has issued urgent recall notices for. Some of the affected products were for sale in Tesco, SuperValu, Dunnes, Lidl, Aldi and other shops across Ireland.

Chicken, beer and ice cream are among the items that the Food Safety Authority of Ireland has issued urgent recall notices for. Some of the affected products were for sale in Tesco, SuperValu, Dunnes, Lidl, Aldi and other shops.

WASHINGTON — The Biden administration is preparing a comprehensive initiative to fight hepatitis C that would streamline testing and treatment and secure an agreement with drugmakers to bring down the cost of treatment of the disease, which has spiked during the pandemic.

Treatments for the hepatitis C have been around since 2013, but high costs and red have slowed efforts to stop the spread.

THOUSANDS of Scots who were infected with hepatitis C or HIV by the NHS will receive £100,000 by the end of the month, the UK Government has…

Patients who were infected with Hepatitis C or HIV in the 1970s and 80s - or their partners - will get the interim compensation payment next week.

As many as 30,000 people were caught up in the contaminated blood scandal

It is estimated about 3,000 people in Scotland were infected with Hepatitis C through NHS blood or blood products in the 1970s through to 1991.

While national efforts to eliminate hepatitis C have faced setbacks because of increased drug use, the impact of COVID-19 and insurance complications, there’s a bright spot: Some states are now making it easier for patients to treat the disease.

States that have traditionally imposed restrictions to costly hepatitis drugs are now lifting those barriers.